Webcast/CME - Drug-Induced Liver Disease, Part 2

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Hepa/Biliary Other

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Hepa/Biliary Other

	Alpha1-Antitrypsin Augmentation: Approaches and Benefits
	Drug-Induced Liver Disease, Part 1
	The Meso-Rex Bypass for Portal Hypertension in Children

Recent news - Hepa/Biliary Other

	Changes Not Affecting Tumour Size May Better Predict Outcomes to Bevacizumab: Presented at RSNA - (DGDispatch)
	Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced Colorectal Cancer - (DGNews)
	New Drug Regimen Shows Promising Results for Advanced Biliary-Tract Cancers - (DGNews)
	Statin use and risk of gallstone disease followed by cholecystectomy - (JAMA)
	What Is the Optimal Timing of Hepatitis C Antiviral Therapy Before and After Liver Transplantation? Presented at AASLD - (DGDispatch)

Recent cases - Hepa/Biliary Other

	Gallstone Ileus An Unusual Reason For Right Iliac Fossa Pain In Crohn's Disease: A Case Report
	Acute Cholangitis Due To Pancreatic Metastasis From Squamous Cell Lung Carcinoma: A Case Report And Review Of Literature
	A Latent Form Of Essential Thrombocythemia Presenting As Portal Cavernoma
	Liver Abscess And Sepsis With Bacillus Pantothenticus In An Immunocompetent Patient: A First Case Report
	Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis

personal edition > hepa/biliary other > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Drug-Induced Liver Disease, Part 2

Presented by:	The University of Alabama School of Medicine
Lecturer	Donald H. Marks, MD, PhD
Approximate duration:	1 hr.
Summary points:	In this text-based CME activity, an expert discusses the potential for acetaminophen (paracetamol) to cause drug-induced liver disease (LD), describes common pathologic presentations of drug-induced LD, lists common clinical manifestations of drug-induced LD, and describes a general approach to treatment of drug-induced LD
Accreditation:	The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit. Expiration Date: June 30, 2012.
Other:	Text-only CME.

Additional Information